Chukwuemeka G. Nzelu-Anene

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

CTCF Mediates the Cis-Regulatory Hubs in Mouse Hearts.

CTCF Mediates the Cis-Regulatory Hubs in Mouse Hearts.

Journal: International journal of molecular sciences

Published: September 10, 2025

Deconstructing the GWAS library: next-generation GWAS.

Deconstructing the GWAS library: next-generation GWAS.

Journal: Physiological reviews

Published: May 23, 2025

Integrative functional genomics analysis identifies pleiotropic genes for vascular diseases.

Integrative functional genomics analysis identifies pleiotropic genes for vascular diseases.

Journal: Nature communications

Published: March 02, 2025

Single cell variant to enhancer to gene map for coronary artery disease.

Single cell variant to enhancer to gene map for coronary artery disease.

Journal: medRxiv : the preprint server for health sciences

Published: November 28, 2024

The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics.

The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics.

Journal: British journal of cancer

Published: September 27, 2024

Atrial fibrillation variant-to-gene prioritization through cross-ancestry eQTL and single-nucleus multiomic analyses.

Atrial fibrillation variant-to-gene prioritization through cross-ancestry eQTL and single-nucleus multiomic analyses.

Journal: iScience

Published: December 14, 2023

A genomic enhancer signature associates with hepatocellular carcinoma prognosis.

A genomic enhancer signature associates with hepatocellular carcinoma prognosis.

Journal: JHEP reports : innovation in hepatology

Published: September 06, 2022

Mitochondria directly interact with the nuclear pore complex.

Mitochondria directly interact with the nuclear pore complex.

Journal: Nature

Published: July 13, 2022

Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development.

Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development.

Journal: Cardiovascular research

Published: June 02, 2022

Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.

Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.

Journal: European journal of heart failure

Published: January 06, 2022

Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.

Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.

Journal: European journal of heart failure

Published: January 06, 2022

8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Exacerbates Doxorubicin-Induced Cardiac Dysfunction.

8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Exacerbates Doxorubicin-Induced Cardiac Dysfunction.

Journal: Oxidative medicine and cellular longevity

Published: September 25, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026